Sumatriptan Succinate Tablets, 100 mg packaged in 9 (1X9) Unit-of-use blister card, (62756-0522-...

FDA Recall #D-0660-2020 — Class II — December 26, 2019

Recall #D-0660-2020 Date: December 26, 2019 Classification: Class II Status: Terminated

Product Description

Sumatriptan Succinate Tablets, 100 mg packaged in 9 (1X9) Unit-of-use blister card, (62756-0522-69), Rx only, Sun Pharma, Cranbury, NJ

Reason for Recall

Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.

Recalling Firm

Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

207,585 blisters

Distribution

Product was distributed throughout the United States to 96 distributors and 1 repacker/relabeler.

Code Information

JKT4174A, exp. date 11/2021 JKU0622A, exp. date 01/2022 JKU1308A, exp. date 02/2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated